Impact of Drug Shortages on Consumer Costs

This report summarizes the findings of a study conducted by the RAND Corporation, which outlines existing and potential tools to address the cost disparities and shortages of drugs. Some data on prescription sales from the Food and Drug Administration (FDA) drug shortage database is also presented. The report also highlights potential policies to address cost increases during shortages and to ensure a sufficient generic drug supply.